About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Prognosis of Cerebral Small Vessel Disease | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05734378

Prognosis of Cerebral Small Vessel Disease

Prognosis of small vessel disease (SVD) depends on the underlying type of SVD and index manifestation. The aim of this prospective, observational cohort study is to determine the risk of different ou...

Lead sponsor: Insel Gruppe AG, University Hospital Bern•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Marianne Kormann

CONTACT

+41 31 632 70 00 [email protected]

Sponsors

Lead Sponsor

Insel Gruppe AG, University Hospital Bern

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Hypertensive deep perforator arteriolopathy (DPA), clinically symptomatic with either ICH, ischaemic stroke, cognitive impairment or severe radiological manifestation (Fazekas ≥II)
•Cerebral amyloid angiopathy (CAA according to modified Boston or Edinburgh criteria), clinically symptomatic with either ICH (including cSAH), amyloid spells, cognitive impairment or severe radiological manifestation (CMB≥2)
•Other SVD (i.e. CADASIL or other sporadic or genetic SVD)

Exclusion Criteria

•Life expectancy of \<6 months due to not-SVD related causes (i.e. cancer)
•Patient is unlikely to attend follow-up visits

Related studies

RECRUITINGPhase 2

A Study of AMDX-2011P in Participants With CAA

NCT05709314 · Cerebral Amyloid Angiopathy

Taiwan Associated Genetic and Nongenetic Small Vessel Disease

NCT05473637 · Cerebral Small Vessel Diseases, Cadasil, and more

Telecoached Exercise Intervention for Connectivity Enhancement in Small Vessel Disease (TELECONNECT-SVD)

NCT06525987 · Lacunar Stroke, Small Vessel Cerebrovascular Disease

The Myelin Disorders Biorepository Project

NCT03047369 · Leukodystrophy, White Matter Disease, and more

RECRUITINGPhase 2

Colchicine for the Prevention of Recurrence in Cerebral Amyloid Angiopathy RElated IntraCerebral Hemorrhage

NCT07026994 · Cerebral Amyloid Angiopathy, Intracerebral Hemorrhage Lobar

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 8, 2023Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment900

Start dateDec 2020

Last updatedMar 8, 2023

Condition

Cerebral Amyloid Angiopathy Small Vessel Cerebrovascular Disease Cadasil CAA - Cerebral Amyloid Angiopathy

Locations shown

Department of Neurology, Inselspital Bern University Hospital

Bern

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 8, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions